Apex Laboratories Private Limited Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Apex Laboratories Private Limited Pharmaceutical Export Portfolio Dataset — 3 Products, $21.9M FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Apex Laboratories Private Limited — Pharmaceutical Exporter Profile (2026) | 3 Products, $21.9M Trade | TransData Nexus

Apex Laboratories Private Limited

Indian Pharmaceutical Exporter · Vitamins & Supplements Specialist · $21.9M Total Trade · DGFT Verified

Apex Laboratories Private Limited is an Indian pharmaceutical exporter with a total trade value of $21.9M across 3 products in 3 therapeutic categories. Based on 437 verified export shipments from Indian Customs (DGFT) records, Apex Laboratories Private Limited is the #1 Indian exporter in 1 product including Zinc. Top exports include Zinc ($12.2M), Gabapentin ($9.3M), Ketorolac ($350.0K).

Apex Laboratories Private Limited — Export Portfolio & Destination Treemap

Apex Laboratories Private Limited pharmaceutical export portfolio — 3 products across 3 therapeutic categories. Source: Indian Customs (DGFT).

Who is Apex Laboratories Private Limited? — Company Overview & Market Position

Apex Laboratories Private Limited, established on July 15, 1978, is a privately held pharmaceutical company headquartered in Chennai, Tamil Nadu, India. The company is classified under the Corporate Identification Number (CIN) U85195TN1978PTC007554. As of the latest available data, Apex Laboratories has an authorized capital of ₹2.75 crore and a paid-up capital of ₹1.83 crore. The company employs over 2,100 individuals, reflecting its significant presence in the Indian pharmaceutical sector. Apex Laboratories specializes in the manufacturing and marketing of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections, with a strong emphasis on quality and ethical marketing practices.

What Does Apex Laboratories Private Limited Export? — Product Portfolio Analysis

Top Products by Export Value

1Zinc$12.2M 2Gabapentin$9.3M

Product Portfolio — Top 3 by Export Value

Apex Laboratories Private Limited exports 3 pharmaceutical products across 3 therapeutic categories. Market leader (#1 exporter) in 1 products.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Zinc	Vitamins & Supplements	$12.2M	243	15.3%	1
2	Gabapentin	CNS & Psychiatric	$9.3M	187	1.1%	8
3	Ketorolac	Analgesics & Antipyretics	$350.0K	7	0.3%	15

Apex Laboratories Private Limited exports 3 pharmaceutical products across 3 therapeutic categories with a total export value of $21.9M. The company is the #1 Indian exporter in 1 product: Zinc. The top category is Vitamins & Supplements (55.6% of portfolio), followed by CNS & Psychiatric (42.8%), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Apex Laboratories Private Limited — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Apex Laboratories operates four state-of-the-art manufacturing plants, each dedicated to specific production needs. These facilities are compliant with current Good Manufacturing Practices (cGMP) as per World Health Organization (WHO) standards and are accredited with ISO 22000:2018 and ISO 14001:2015 certifications by TUV SUD. The plants are strategically located to cater to both domestic and international markets, with one facility exclusively designed for regulated markets. Additionally, Apex Laboratories offers contract manufacturing services, providing cost-effective solutions for global companies seeking production capabilities in India.

3Key Leadership

The company is led by Chairman & Managing Director Mr. S.S. Vanangamudi, who has been at the helm since its inception in 1978. Other key executives include Mr. Sulur Vanangamudi Subramaniam, Whole-Time Director since October 1, 2012, and Mr. Thangavelu Mannavan, Director since May 14, 2014. The leadership team is committed to upholding the company's values of quality, ethical marketing, and continuous technological advancement.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Apex Laboratories Private Limited Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Apex Laboratories has established a robust presence in regulated markets, including the United States, European Union, United Kingdom, Australia, and Japan. The company has obtained necessary regulatory approvals and maintains compliance with the stringent standards set by these regions. This compliance ensures the safety, efficacy, and quality of its pharmaceutical products, facilitating access to these lucrative markets. Apex Laboratories' adherence to international regulatory requirements underscores its commitment to global standards and positions it as a competitive player in the global pharmaceutical industry.

2Emerging Markets

Apex Laboratories has strategically expanded its footprint into emerging markets across Africa, Latin America, and Southeast Asia. The company's products are exported to over 25 countries worldwide, reflecting its growing international presence. By obtaining WHO prequalification, Apex Laboratories has enhanced its credibility and facilitated access to these markets, enabling it to meet the specific health needs of diverse populations. This expansion aligns with the company's vision to be a leading player in the global pharmaceutical industry and a household name in healthcare.

3Geographic Strategy

Apex Laboratories Private Limited — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Apex Laboratories has registered its manufacturing facilities with the U.S. Food and Drug Administration (FDA), ensuring compliance with U.S. regulatory standards. The company has obtained approvals for its Abbreviated New Drug Applications (ANDAs), allowing it to market generic pharmaceutical products in the United States. Additionally, Apex Laboratories has filed Drug Master Files (DMFs) with the FDA, providing detailed information about the manufacturing processes and quality controls of its products. The company's facilities have undergone FDA inspections, which have been completed satisfactorily, further affirming its commitment to maintaining high-quality standards.

2WHO & EU GMP

Apex Laboratories' manufacturing facilities are certified by the World Health Organization's Good Manufacturing Practices (WHO-GMP), reflecting adherence to international quality standards. The company has also obtained EU GMP certificates, demonstrating compliance with the European Union's stringent manufacturing requirements. These certifications are crucial for accessing and maintaining a presence in regulated markets, ensuring that Apex Laboratories' products meet the safety and efficacy expectations of international consumers.

CDSCO & Indian Regulatory

Apex Laboratories Private Limited — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Apex Laboratories operates in a competitive pharmaceutical market, facing competition from both domestic and international companies. In the vitamins and supplements segment, the company holds a significant market share, with its flagship product, Zincovit, being a brand leader in India. In the CNS and psychiatric segment, Apex Laboratories offers products like Gabapentin, contributing to its diverse portfolio. The company's focus on quality, ethical marketing, and continuous technological advancement has enabled it to establish a strong presence in these therapeutic categories, differentiating it from competitors.

2Key Differentiators

Apex Laboratories' key differentiators include its pioneering role in introducing zinc-based formulations in India, with Zincovit being a market leader in the multivitamin and mineral supplements segment. The company's commitment to quality is demonstrated through its WHO-GMP certification and ISO accreditations. Additionally, Apex Laboratories' diversified product portfolio across therapeutic categories and its expansion into herbal products showcase its adaptability and responsiveness to market demands.

3Strategic Position

Buyer Due Diligence Brief — Evaluating Apex Laboratories Private Limited as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Apex Laboratories has demonstrated a strong track record in manufacturing and exporting pharmaceutical products, with a total export value of $21.9 million USD and 437 shipments across three therapeutic categories. The company's portfolio concentration is notable, with its top five products accounting for 100% of its exports. This focus indicates a strategic approach to product development and market positioning. Apex Laboratories' consistent growth and adherence to quality standards underscore its reliability as a supplier in the pharmaceutical industry.

2Certifications to Verify

Importers should verify the following certifications to ensure the quality and compliance of Apex Laboratories' products:

FDA Facility Registration: Confirm that the manufacturing facilities are registered with the U.S. Food and Drug Administration.

WHO-GMP Certification: Ensure that the facilities are certified by the World Health Organization's Good Manufacturing Practices.

Frequently Asked Questions — Apex Laboratories Private Limited

How many pharmaceutical products does Apex Laboratories Private Limited export from India?

Apex Laboratories Private Limited exports 3 pharmaceutical products across 3 therapeutic categories. The top exports are Zinc ($12.2M), Gabapentin ($9.3M), Ketorolac ($350.0K). Total export value is $21.9M.

What is Apex Laboratories Private Limited's total pharmaceutical export value?

Apex Laboratories Private Limited's total pharmaceutical export value is $21.9M, based on 437 verified shipments recorded in Indian Customs (DGFT) data.

In which products is Apex Laboratories Private Limited the #1 Indian exporter?

Apex Laboratories Private Limited is the #1 Indian exporter in 1 products: Zinc (15.3% market share).

What therapeutic categories does Apex Laboratories Private Limited cover?

Apex Laboratories Private Limited exports across 3 therapeutic categories. The largest are Vitamins & Supplements (55.6%, 1 products), CNS & Psychiatric (42.8%, 1 products), Analgesics & Antipyretics (1.6%, 1 products).

Get Full Apex Laboratories Private Limited Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.